Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × PM 01183 × NET × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

INDUSTRY 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1 Adenoma, Islet Cell 1

Interventions

olaparib 1 copper dotatate CU-64 1 Tomography, Emission-Computed, Single-Photon 1 PM 01183 1 Lutetium-177 1 Irinotecan 1 Iodine-124 1 Iodine-123 1 Injections 1 Etoposide 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07121478 2025-10-01

Patients With High-grade Pancreatic Neuroendocrine Tumors

National Cancer Center, Korea

Phase 2 Enrolling by invitation

Adenoma, Islet Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡